Avalere Health has ranked #16 in the 2024 MM+M Agency 100, cementing our position as one of the leading medical marketing agencies in North America. This is our fifth year in a row ranking in the prestigious list, and our first since rebranding from Fishawack Health to Avalere Health in October 2023.

In a challenging year for the biopharmaceutical industry, we are proud to be one of the only agencies of our size to have demonstrated double-digit growth in 2023.

To celebrate, we have outlined three ways we are driving the innovation that helped us secure a place at the top of the list – from uniting as one Avalere Health to launching a new Payer Marketing Agency offering.

In a market saturated with sub-brands and spin-offs, it takes courage and tenacity to unite as one

“The last year was one of the most important in our company’s history, since our inception in 2001,” says Jon Koch, CEO.  “We rebranded as Avalere Health and became the only global organization of our size to go to market as one brand, with one united solution set, delivering from advisory to execution at every stage of the product lifecycle.”

On October 18, 2023, we made the bold move to rebrand from Fishawack Health to Avalere Health – a single unified commercialization partner, acting and moving as one. In doing so, we retired a dozen heritage brands and unified our 1,500+ experts across three continents under a shared purpose, culture, values, infrastructure, and global brand.

Uniting under one ethos, one brand, one vision, and one united service set, the rebrand announced our connected commercialization proposition. It forged our ability to rapidly mobilize tailor-made teams to deliver best-in-class solutions for our clients.

Today our Consulting; Medical; Policy, Access, Value and Evidence; Marketing; and Digital Experience Technology experts leverage their collective intelligence to provide a 360-degree perspective of the landscape, building unity across the treatment journey and driving sustainable change in clinical settings.

‘’From determining the value of an asset as early as possible to ensuring every patient is valued, we operate without boundaries, connecting science and creativity, technology and data, ability and agility, to solve healthcare’s most complex challenges,” explains Koch.

Uniting renowned market access strategy expertise with award-winning marketing to solve one of the greatest challenges for patients: access.

More recently we launched our Payer Marketing Agency offering, demonstrating the value of our integrated approach. Bringing together renowned market access expertise and award-winning marketing, this new capability provides clients with strategic and creative solutions to accelerate access to innovative brands.

Driving access takes more than payer formulary placement. Across the access continuum, numerous influences impact a patient’s journey to treatment and care. From engaging payers to creating strategies for reimbursement and patient affordability, our Payer Marketing Agency designs and executes brand access planning and materials to effectively engage access stakeholders.

“We have brought together our market access specialists and talented marketers to accelerate access for patients in North America. ,” explains Amar Urhekar, Chief Operating Officer.

Importantly our strategists and creatives are equipped with a staggering amount of data, providing an end-to-end view of the patient journey, including open and closed claims data representing all payer markets, formulary and benefit design data, clinical data, and data on the social determinants of health, as well as patient programs, digital interactions, devices, the market, and more.

“In today’s market, it is more important than ever to leverage data and generate the insights needed to drive agile strategies that grow as the landscape evolves. Data alone doesn’t ensure that payers and customers are compelled to act, it is the storytelling through the eyes of the patient journey that differentiates a brand,” says Mario Muredda, President of Marketing.

Combining AI, data, and technology to power omnichannel engagements

As MM+M reports, several barriers prevent biopharmaceutical companies from realizing the promise of AI, including a lack of guidance on using the technology in the real world.

We are supporting our clients to navigate the landscape and leverage the technology ethically to connect with millions of people across the globe seamlessly and in a highly tailored way.

During the past year, we have developed a robust AI and data-powered omnichannel ecosystem, which connects humans and data using interactive interfaces, machine learning, and generative AI to automate insights and accelerate decisions.

The ecosystem empowers our strategists, scientists, creatives, analysts, and technologists to build detailed 360-degree views of the market landscape and audiences, which they strategically leverage to develop agile and personalized omnichannel experiences that evolve as brands grow and the market changes.

Data is the backbone of our approach. Our data platform aggregates data from hundreds of datasets–including claims, pharmacy, formulary, market, and audience data. This includes deep analysis of customer and consumer audience behavior and emotional sentiment powered by our omnichannel platform, Inspire. The platform fuels personalization and powers a living and breathing brand ecosystem that allows for real-time learning and optimization.

AI is best used as an accelerant to further our strategies. Our ecosystem includes innovative tools including a generative AI toolkit complete with our proprietary Avalere Health GPT. These tools support our experts in developing engagement strategies, accelerating decision-making, and building powerful executions that drive relevance and connection, inspiring audiences to act.

“We are a connected community of experts who think big as well as deep to deliver powerfully together. We have invested in Gen AI to enrich our human ingenuity and help our experts think bigger, dive deeper, and deliver more powerfully for our clients,” explains Geoff Thorne, Chief Technology Officer.